G
Glycos Biotechnologies
International biochemical company commercializing sustainable chemicals made from renewable feedstocks
About Glycos Biotechnologies
Glycos Biotechnologies is a life sciences company focused on developing engineered lipid-based technologies to enhance the delivery and performance of natural bioactive molecules. The company's research and development efforts are centered on creating solutions for the nutritional and therapeutic industries.
GlycosBio has developed a library of "Activated Oil Systems" designed to selectively target harmful pathogens while preserving beneficial bacteria, which has applications in skincare and microbiota research. Additionally, the company designs personalized nutritional lipid systems to improve the bioavailability of essential nutrients and building blocks for the body. Their business model appears to be B2B, collaborating with medical professionals and scientific advisors to design these systems for therapeutic and over-the-counter (OTC) skincare products as well as nutritional supplements. The company serves clients in the pharmaceutical, cosmetic, and food science sectors.
Source: Dealroom company dataNews
Open roles
Glycos Biotechnologies in the Houston ecosystem
The Glycos Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Mercury Fund
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Glycos Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Glycos Biotechnologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

